United States of America vs Uruguay: New cases tested for RR-/MDR-TB
United States of America
91.0%
in 2023
Uruguay
91.0%
in 2024
United States of America rank
91st
Uruguay rank
91st
New cases tested for RR-/MDR-TB over time
- United States of America
- Uruguay
How they compare
United States of America currently reports 91.0% against 91.0% in Uruguay, a difference of 0.0%.
The two have swapped places 2 times across 17 shared years of data; in 2006 it was United States of America ahead.
United States of America ranks 91st and Uruguay ranks 91st of 192 countries.
United States of America has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | United States of America | Uruguay | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 100.0% | 93.0% | 7.0% | United States of America |
| 2010s | 98.3% | 78.7% | 19.6% | United States of America |
| 2020s | 93.2% | 80.2% | 13.0% | United States of America |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher new cases tested for rr-/mdr-tb, United States of America or Uruguay?
- United States of America, at 91.0% against 91.0% in Uruguay as of 2023.
- What is the difference in new cases tested for rr-/mdr-tb between United States of America and Uruguay?
- 0.0%, with United States of America ahead.
- How many years of comparable data are there for United States of America and Uruguay?
- 17 years are reported by both, from 2006 to 2023.
- How do United States of America and Uruguay rank globally for new cases tested for rr-/mdr-tb?
- United States of America ranks 91st and Uruguay ranks 91st of 192 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as New cases tested for RR-/MDR-TB (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.